We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$118M
AUM Growth
+$5.92M
Cap. Flow
+$2.18M
Cap. Flow %
1.84%
Top 10 Hldgs %
23.44%
Holding
89
New
6
Increased
35
Reduced
24
Closed

Sector Composition

Rank Sector Weight
1 Industrials 14.03%
2 Technology 12.71%
3 Consumer Staples 11.34%
4 Healthcare 10.79%
5 Financials 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
76
Bristol-Myers Squibb
BMY
$129B
$298K 0.25%
6,452
+192
+3% +$8.43K
NEE icon
77
NextEra Energy
NEE
$185B
$291K 0.25%
14,560
OXY icon
78
Occidental Petroleum
OXY
$55.7B
$285K 0.24%
3,184
FAST icon
79
Fastenal
FAST
$54.8B
$264K 0.22%
21,040
VZ icon
80
Verizon
VZ
$197B
$263K 0.22%
5,637
+1,135
+25% +$55.4K
EFOR
81
Everforth Inc
EFOR
$960M
$246K 0.21%
+7,482
New +$232K
ORCL icon
82
Oracle
ORCL
$339B
$230K 0.19%
6,938
DD
83
DELISTED
Du Pont De Nemours E I
DD
$224K 0.19%
+4,038
New +$221K
CAT icon
84
Caterpillar
CAT
$361B
$216K 0.18%
2,592
+80
+3% +$6.77K
GAS
85
DELISTED
AGL Resources Inc
GAS
$213K 0.18%
+4,634
New +$209K
DHR icon
86
Danaher
DHR
$138B
$207K 0.17%
+4,463
New +$202K
GPC icon
87
Genuine Parts
GPC
$17.9B
$205K 0.17%
+2,540
New +$206K
HPQ icon
88
HP
HPQ
$26B
$203K 0.17%
21,315

Similar funds

Boston Research & Management's Q3 2013 Portfolio in Review

As of Q3 2013, Boston Research & Management held 89 positions worth $118M, up 5.3% from $112M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boston Research & Management's Q3 2013 filing shows 6 new, 35 increased and 24 reduced positions. Its largest new stake was Everforth Inc: 7,482 shares worth $246K. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $169K.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Staples.

  • Boston Research & Management's largest Q3 2013 buy was Everforth Inc: 7,482 shares worth $246K.
  • Boston Research & Management added most to Xylem in Q3 2013, an estimated $232K increase.
  • Boston Research & Management's biggest Q3 2013 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $169K.
  • Boston Research & Management's ten largest holdings make up 23% of its $118M portfolio in Q3 2013.
  • Boston Research & Management opened 6 new positions and closed 0 in Q3 2013.
  • Boston Research & Management's portfolio value rose 5.3% quarter-over-quarter to $118M.

Based on Boston Research & Management's 13F filing for Q3 2013, filed 8 Nov 2013.